Traumatic brain injury (TBI) has a complex pathophysiology that hinders the development of rapid biofluid-based diagnostic tests for the management of patients with TBI. A panel of neuronal injury biomarkers may be a potential solution to access multi-component pathology of brain injury. Biomarkers in TBI can help identify neuronal damage and predict outcomes following concussion.
Explore our interactive poster on biomarkers in TBI and find the best products for your target of interest.
Download now
Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send. By filling out this form you consent to Abcam sharing your details with your local, authorized distributor for the purpose of answering your query.